Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples